ReviewPharmaceutics2021

Combination Therapy of Navitoclax with Chemotherapeutic Agents in Solid Tumors and Blood Cancer: A Review of Current Evidence.

Nur Syahidah Nor Hisam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.